Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Escudier, Bernard J.
Iacovelli, Roberto
Lanoy, Emilie
Albiges, Laurence
Fizazi, Karim
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Roma La Sapienza, Deparment Radiol Oncol & Human Pathol, Oncol Unit, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
397
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic impact of lymphnode metastasis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Ivanyi, P.
    Tiemann, M. -L.
    Eggers, H.
    Reuter, C.
    Peters, I.
    Kuczyk, M.
    Ganser, A.
    Gruenwald, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [22] Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) - a validation study
    Pond, G. R.
    Dietrich, M.
    Gruenwald, V.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
    Wei, Zongjie
    Zhang, Fan
    Ma, Xin
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    TRANSLATIONAL ONCOLOGY, 2022, 23
  • [24] Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma
    Gu, Liangyou
    Ma, Xin
    Xie, Yongpeng
    Li, Hongzhao
    Wang, Lei
    Chen, Luyao
    Zhao, Wenlei
    Zhang, Yu
    Zhang, Xu
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E369 - E377
  • [25] Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
    U M Vogl
    H Zehetgruber
    M Dominkus
    M Hejna
    C C Zielinski
    A Haitel
    M Schmidinger
    British Journal of Cancer, 2006, 95 : 691 - 698
  • [26] Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
    Vogl, U. M.
    Zehetgruber, H.
    Dominkus, M.
    Hejna, M.
    Zielinski, C. C.
    Haitel, A.
    Schmidinger, M.
    BRITISH JOURNAL OF CANCER, 2006, 95 (06) : 691 - 698
  • [27] Effect of nivolumab on tumor growth rate (TGR) in metastatic renal cell carcinoma (mRCC).
    Mazza, Camille
    Arfi-Rouche, Julia
    Koscielny, Serge
    Caramella, Caroline
    Lahmar, Jihene
    Escudier, Bernard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [28] Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
    Zengin, Zeynep Busra
    Dizman, Nazli
    Salgia, Nicholas
    Jones, Jeremy
    Zhang, Jingbo
    Liu, Yunchao
    Xu, Bing
    Li, Fuwei
    Wang, Yan
    Li, Mengjian
    Du, Rong
    Zhou, Ye
    Hsu, Joann
    Salgia, Meghan
    Yang, Lixin
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] TUMOR NECROSIS AS PROGNOSTIC FACTOR OF RENAL CELL CARCINOMA
    Hiros, M.
    Selimovic, M.
    Spahovic, H.
    Sadovic, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 591 - 591
  • [30] Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
    A N Jeppesen
    H K Jensen
    F Donskov
    N Marcussen
    H von der Maase
    British Journal of Cancer, 2010, 102 : 867 - 872
12345